Works matching IS 14764598 AND DT 2013 AND VI 12 AND IP 1


Results: 175
    1
    2
    3
    4
    5

    Cancer risk in immune-mediated inflammatory diseases (IMID).

    Published in:
    Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-98
    By:
    • Beyaert, Rudi;
    • Beaugerie, Laurent;
    • Van Assche, Gert;
    • Brochez, Lieve;
    • Renauld, Jean-Christophe;
    • Viguier, Manuelle;
    • Cocquyt, Veronique;
    • Jerusalem, Guy;
    • Machiels, Jean-Pascal;
    • Prenen, Hans;
    • Masson, Pierre;
    • Louis, Edouard;
    • Keyser, Filip De
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    FGFR3 has tumor suppressor properties in cells with epithelial phenotype.

    Published in:
    Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-83
    By:
    • Lafitte, Marie;
    • Moranvillier, Isabelle;
    • Garcia, Stéphane;
    • Peuchant, Evelyne;
    • Iovanna, Juan;
    • Rousseau, Benoit;
    • Dubus, Pierre;
    • Guyonnet-Dupérat, Véronique;
    • Belleannée, Geneviève;
    • Ramos, Jeanne;
    • Bedel, Aurélie;
    • Verneuil, Hubert de;
    • Moreau-Gaudry, François;
    • Dabernat, Sandrine
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    TMEM16A alternative splicing coordination in breast cancer.

    Published in:
    Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-75
    By:
    • Ubby, Ifeoma;
    • Bussani, Erica;
    • Colonna, Antonio;
    • Stacul, Giuseppe;
    • Locatelli, Martina;
    • Scudieri, Paolo;
    • Galietta, Luis;
    • Pagani, Franco
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na<sup>+</sup>/K<sup>+</sup>-ATPase.

    Published in:
    Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-33
    By:
    • Banuls, Laetitia Moreno Y.;
    • Katz, Adriana;
    • Miklos, Walter;
    • Cimmino, Alessio;
    • Tal, Daniel M.;
    • Ainbinder, Elena;
    • Zehl, Martin;
    • Urban, Ernst;
    • Evidente, Antonio;
    • Kopp, Brigitte;
    • Berger, Walter;
    • Feron, Olivier;
    • Karlish, Steven;
    • Kiss, Robert
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary.

    Published in:
    Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-57
    By:
    • Pentheroudakis, George;
    • Pavlidis, Nicholas;
    • Fountzilas, George;
    • Krikelis, Dimitrios;
    • Goussia, Anna;
    • Stoyianni, Aikaterini;
    • Sanden, Mats;
    • Cyr, Brianna St.;
    • Yerushalmi, Noga;
    • Benjamin, Hila;
    • Meiri, Eti;
    • Chajut, Ayelet;
    • Rosenwald, Shai;
    • Aharonov, Ranit;
    • Spector, Yael
    Publication type:
    Article
    50